Topic hub
Why patients stay on a medicine, and why they stop
Adherence as patients describe it: side effects, cost, routine, and the moment a prescription quietly lapses.
What did the panels say about why patients stay on a medicine, and why they stop?
- #
48.5%
48.5% would stop the blood pressure pill once its copay rose from $15 to $60 a month, on top of no felt benefit and afternoon tiredness, up from 14.0% with the tiredness alone and 1.5% with no felt benefit alone. — Patient adherence breaks at the copay: 48.5% would stop a daily blood pressure pill when it jumps from $15 to $60 a month
base 200
- #
35%
35.0% would stay on an antidepressant that is helping at $150 a month, against 82.2% at $50 and 97.0% at $10; no clone rates itself more likely to stay on at a higher price. — Antidepressant cost: only 35.0% of US adults prescribed one for depression would stay on it at $150 a month, against 82.2% at $50
base 197
- #
98%
A follow-up blood test showing cholesterol down by a third lifts the share of US adults very likely to still be taking a daily statin a year later from 74.5% to 98.0%; automatic home delivery every three months at the same $10 a month lifts it to 80.5%. Every case had no side effects and no change in how the person feels. — Seeing it work keeps US adults on a statin they cannot feel: a cholesterol test result wins over 92.2% of those not yet certain, home delivery 27.5%, and a $30 a month rise is the top reason to stop below $50,000 a year
base 200
- #
67%
67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost. — Side-effect fears hold back 67.0% of US adults from a recommended statin, and a test of their own heart risk, not a lower price, is what would change their minds
base 200
- #
0
There is no cheap nudge. Not one person in 200 would proceed for less than $1,000. — Cash to go ahead with a delayed $3,000 treatment: no US adult would for under $1,000, and 97 of 200 would need the full $3,000
base 200
What has Brox published on why patients stay on a medicine, and why they stop?Newest first
-
Patient adherence breaks at the copay: 48.5% would stop a daily blood pressure pill when it jumps from $15 to $60 a month
48.5% 48.5% would stop the blood pressure pill once its copay rose from $15 to $60 a month, on top of no felt benefit and afternoon tiredness, up from 14.0% with the tiredness alone and 1.5% with no felt benefit alone. (base 200)
Read -
Antidepressant cost: only 35.0% of US adults prescribed one for depression would stay on it at $150 a month, against 82.2% at $50
35% 35.0% would stay on an antidepressant that is helping at $150 a month, against 82.2% at $50 and 97.0% at $10; no clone rates itself more likely to stay on at a higher price. (base 197)
Read -
Seeing it work keeps US adults on a statin they cannot feel: a cholesterol test result wins over 92.2% of those not yet certain, home delivery 27.5%, and a $30 a month rise is the top reason to stop below $50,000 a year
98% A follow-up blood test showing cholesterol down by a third lifts the share of US adults very likely to still be taking a daily statin a year later from 74.5% to 98.0%; automatic home delivery every three months at the same $10 a month lifts it to 80.5%. Every case had no side effects and no change in how the person feels. (base 200)
Read -
Side-effect fears hold back 67.0% of US adults from a recommended statin, and a test of their own heart risk, not a lower price, is what would change their minds
67% 67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost. (base 200)
Read -
Cash to go ahead with a delayed $3,000 treatment: no US adult would for under $1,000, and 97 of 200 would need the full $3,000
0 There is no cheap nudge. Not one person in 200 would proceed for less than $1,000. (base 200)
Read -
When a pharmacy closes, 89% would stay with the same chain, and an on-time guarantee holds them better than a discount
89% A store closing moves almost nobody off the chain: 89% (178 of 200) would keep their prescriptions with it. (base 200)
Read
What do people ask about why patients stay on a medicine, and why they stop?
- Why do patients stop taking a daily medicine after the first few months, and what would keep them on it?
- 48.5% of US adults who take a daily prescription medicine (n=200, November 2026) would stop a new blood pressure pill once its copay rose from $15 to $60 a month on top of no felt benefit and afternoon tiredness, against 14.0% before the copay rise and 1.5% with no side effect at all.Read the insight
- Why do US adults with depression stop an antidepressant, and what would have kept them on it?
- Cost and side effects: 82.2% of US adults prescribed an antidepressant for depression would stay on one that helps at $50 a month but 35.0% at $150, and 51.3% say a quick switch when side effects bother them would keep them on it (n=197, November 2026).Read the insight
- What makes a patient with high cholesterol take a statin every day when they feel fine?
- Seeing it work keeps US adults on a daily statin they feel no different on: a follow-up blood test showing cholesterol down by a third lifts the share very likely to still be taking it a year later from 74.5% to 98.0% (n=200, October 2026), while automatic home delivery lifts it only to 80.5%.Read the insight
- What stops patients starting a preventive medicine their doctor has recommended?
- Worry about side effects is the main thing that would stop 67.0% of US adults starting a daily statin their doctor recommends while they feel well (n=200, October 2026), while 62.5% say a test showing their own heart risk is high would most persuade them to start, against 1.0% who name a lower price.Read the insight
- When a health plan deductible leaves a needed treatment costing about $3,000 out of pocket, how large does a cash payment have to be before people go ahead with it, and does it matter whether the money arrives before or after the treatment?
- Not one of 200 US adults would go ahead with a $3,000 treatment they had been putting off for a cash payment under $1,000, and 97 of the 200 need the full $3,000 back, September 2026.Read the insight
- Where do people move their prescriptions when the pharmacy store filling them closes, and what would keep them with the same chain?
- 89% of US pharmacy users (178 of 200) would keep their prescriptions with the same chain when their store closes, and a guarantee the prescription is ready on time is the strongest thing that holds them (75.5%), while a discount is the weakest (36.5%), September 2026.Read the insight
Other topics
How should you read these findings?
Where the numbers come from. Every figure on this site is a predicted response from Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The base under each figure is the number of clones behind it.
Where the real data comes from. The long-form video interviews with the real people the clones are built from. A quote is always shown with the interview line it was predicted from.
What you can take away. Insights publish their tabulation as CSV and JSON: question, option, count, percentage and base. Never per-person rows.
Ask this of your own customers: humans@brox.ai